Cargando…

Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017

OBJECTIVE: to investigate sociodemographic and clinical characteristics of users of atypical antipsychotics receiving care via the Specialized Component of Pharmaceutical Assistance (Componente Especializado da Assistência Farmacêutica - CEAF), for the treatment of schizophrenia in Brazil, between 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fulone, Izabela, Silva, Marcus Tolentino, Lopes, Luciane Cruz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Secretaria de Vigilância em Saúde - Ministério da Saúde do Brasil 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072313/ https://www.ncbi.nlm.nih.gov/pubmed/36946832 http://dx.doi.org/10.1590/S2237-96222023000300015

Ejemplares similares

Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Long-term benzodiazepine use in patients taking antidepressants in a public health setting in Brazil: a cross-sectional study
por: Fulone, Izabela, et al.
Publicado: (2018)

Risks of Adverse Neonatal Outcomes in Early Adolescent Pregnancy Using Group Prenatal Care as a Strategy for Public Health Policies: A Retrospective Cohort Study in Brazil
por: Honorato, Danylo José Palma, et al.
Publicado: (2021)

Factors associated with thrombocytopenia in patients with dengue fever: a retrospective cohort study
por: Castilho, Bruna M, et al.
Publicado: (2020)

Potentially inappropriate prescriptions for elderly people taking antidepressant: comparative tools
por: Fulone, Izabela, et al.
Publicado: (2017)

Improving Care for Deinstitutionalized People With Mental Disorders: Experiences of the Use of Knowledge Translation Tools
por: Fulone, Izabela, et al.
Publicado: (2021)

Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: A methodological survey
por: Mazzei, Lauren Giustti, et al.
Publicado: (2020)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Late adverse effects related to treatment in a cohort of survivors of childhood and adolescent cancer
por: Livinalli, Annemeri, et al.
Publicado: (2019)

Use of second-generation antipsychotics in autism spectrum disorder: a systematic review and meta-analysis protocol
por: Lopes, Luis Phillipe Nagem, et al.
Publicado: (2023)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Limitations in the comparison of the Brazilian National Dietary Surveys of 2008–2009 and 2017–2018
por: Rodrigues, Renata Muniz, et al.
Publicado: (2021)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil
por: Barbosa, Wallace Breno, et al.
Publicado: (2018)

Dietary patterns of Brazilian adults in 2008–2009 and 2017–2018
por: Antunes, Anna Beatriz Souza, et al.
Publicado: (2021)

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting
por: de Camargo, Mayara Costa, et al.
Publicado: (2019)

Knowledge Translation for Improving the Care of Deinstitutionalized People With Severe Mental Illness in Health Policy
por: Fulone, Izabela, et al.
Publicado: (2020)

Improving the adherence to COVID-19 preventive measures in the community: Evidence brief for policy
por: Fulone, Izabela, et al.
Publicado: (2022)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2006)

Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia
por: Fujimaki, Koichiro, et al.
Publicado: (2012)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
por: Khasawneh, Fadi T., et al.
Publicado: (2014)

A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
por: Gilca, Marilena, et al.
Publicado: (2014)

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia
por: MacEwan, Joanna P., et al.
Publicado: (2016)

Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study
por: Ahmadkhaniha, Hamid-Reza, et al.
Publicado: (2014)

Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil
por: Del Fiol, Fernando de Sá, et al.
Publicado: (2023)

Critical appraisal and comparison of recommendations of clinical practice guidelines for treatment of schizophrenia in children and adolescents: a methodological survey protocol
por: Alves, Maíra Ramos, et al.
Publicado: (2020)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs
por: Kucharska-Pietura, Katarzyna, et al.
Publicado: (2012)

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
por: McEvoy, Joseph, et al.
Publicado: (2013)

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2012)

Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
por: Kang, Shi Hyun, et al.
Publicado: (2015)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
por: O’Day, Ken, et al.
Publicado: (2013)

Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
por: Chen, Yi-Lung, et al.
Publicado: (2018)

Effects of zinc sulfate on schizophrenia symptoms in patients undergoing atypical antipsychotic pharmacotherapy
por: Behrouzian, Forouzan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ev7v57sfqeuccr855417ip4hov